Jenamicin
Brand names,
Jenamicin
Analogs
Jenamicin
Brand Names Mixture
- Diprogen Crm (Betamethasone Dipropionate + Gentamicin Sulfate)
- Diprogen Ont (Betamethasone Dipropionate + Gentamicin Sulfate)
- Garasone Oph/Ot Sol (Betamethasone + Gentamicin Sulfate)
- Garasone Ophthalmic Ointment (Betamethasone + Gentamicin Sulfate)
- Gentamicin Sulfate in Nacl 0.9% Inj (Gentamicin Sulfate + Sodium Chloride)
- Gentamicin Sulfate in Nacl 0.9% Inj (Gentamicin Sulfate + Sodium Chloride)
- Gentocin Durafilm (Betamethasone 21-Acetate + Gentamicin Sulfate)
- Gentocin Otic Solution (Betamethasone + Gentamicin Sulfate)
- Otomax Ointment (Betamethasone + Clotrimazole + Gentamicin Sulfate)
- Sandoz Pentasone (Betamethasone + Gentamicin Sulfate)
- Topagen Ont (Betamethasone + Gentamicin Sulfate)
- Topagen Spray (Betamethasone + Gentamicin Sulfate)
- Valisone G Cream (Betamethasone + Gentamicin Sulfate)
- Valisone G Ointment (Betamethasone + Gentamicin Sulfate)
Jenamicin
Chemical_Formula
C21H43N5O7
Jenamicin
RX_link
http://www.rxlist.com/cgi/generic2/pedgenta.htm
Jenamicin
fda sheet
Jenamicin
msds (material safety sheet)
Jenamicin
Synthesis Reference
No information avaliable
Jenamicin
Molecular Weight
477.596 g/mol
Jenamicin
Melting Point
105°C (218-237°C as sulfate salt)
Jenamicin
H2O Solubility
100 mg/mL
Jenamicin
State
Solid
Jenamicin
LogP
-3.637
Jenamicin
Dosage Forms
Cream; Drops; Liquid; Ointment; Solution
Jenamicin
Indication
For treatment of serious infections caused by susceptible strains of the following microorganisms: P. aeruginosa, Proteus species (indole-positive and indole-negative), E. coli, Klebsiella-Enterobactor-Serratia species, Citrobacter species and Staphylococcus species (coagulase-positive and coagulase-negative).
Jenamicin
Pharmacology
Gentamicin is a broad spectrum aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more potent and less damaging to the host. In the past the aminoglycosides have been used in conjunction with penicillin-related antibiotics in streptococcal infections for their synergistic effects, particularly in endocarditis. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.
Jenamicin
Absorption
Injections lead to peak serum concentrations in 30-60 minutes. Topical gentamicin is readily absorbed from large burned, denuded, or granulating areas but not through intact skin. Absorption of gentamicin is faster and greater with the cream compared to the ointment. Gentamicin is absorbed in small quantities following topical application to the eye. Gentamicin is also absorbed in small amounts following topical application to the ear (especially if the eardrum is perforated or if tissue damage is present).
Jenamicin
side effects and Toxicity
Mouse, intravenous LD50: 52 mg/kg; rat, intravenous LD50: 96 mg/kg.
Jenamicin
Patient Information
No information avaliable
Jenamicin
Organisms Affected
Enteric bacteria and other eubacteria